Your browser doesn't support javascript.
loading
HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo.
Hobbs, Charlotte V; Neal, Jillian; Conteh, Solomon; Donnelly, Liam; Chen, Jingyang; Marsh, Kennan; Lambert, Lynn; Orr-Gonzalez, Sachy; Hinderer, Jessica; Healy, Sara; Borkowsky, William; Penzak, Scott R; Chakravarty, Sumana; Hoffman, Stephen L; Duffy, Patrick E.
Afiliação
  • Hobbs CV; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
  • Neal J; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
  • Conteh S; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
  • Donnelly L; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
  • Chen J; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
  • Marsh K; AbbVie Inc., North Chicago, Illinois, United States of America.
  • Lambert L; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
  • Orr-Gonzalez S; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
  • Hinderer J; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
  • Healy S; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
  • Borkowsky W; Division of Infectious Disease and Immunology, Department of Pediatrics, New York University School of Medicine, New York, New York, United States of America.
  • Penzak SR; Clinical Center Pharmacy Department, Clinical Pharmacokinetics Research Laboratory, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
  • Chakravarty S; Sanaria, Inc. Rockville, Maryland, United States of America.
  • Hoffman SL; Sanaria, Inc. Rockville, Maryland, United States of America.
  • Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
PLoS One ; 9(7): e100138, 2014.
Article em En | MEDLINE | ID: mdl-24988386

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Sulfadoxina / Trimetoprima / Malária Falciparum / Inibidores da Protease de HIV / Ritonavir / Lopinavir / Antimaláricos Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Sulfadoxina / Trimetoprima / Malária Falciparum / Inibidores da Protease de HIV / Ritonavir / Lopinavir / Antimaláricos Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos